December 13, 2012

Introducing our Expanded Cancer Gene Set

Genomics and Pathology Services (GPS) at Washington University School of Medicine in St. Louis introduces its second generation oncology sequencing test this January. The test offers comprehensive analysis of tumor somatic mutations in 40 oncogenes, tumor suppressors, and other cancer genes.
   
Oncology gene set results assist oncologists with stratification of disease subtypes and permit tailoring of effective personalized therapies. For instance, the detection of somatic mutations in recurrent cancers may point to the use of specific targeted therapies.
 
The test employs targeted capture and next-generation sequencing in GPS’s CAP/CLIA labs for deep, comprehensive coverage of all coding exons in all 40 genes. Results are accompanied by concise, expert interpretations from our board-certified clinical genomicists.
 
GPS performs insurance precertification, coordinates specimen acquisition, and performs pathologic evaluation of specimens to ensure testing is performed on neoplastic tissue.
 
To order a test, submit a requisition or call 314.747.7337 or 1.866.450.7697 for more information.